Stocklytics Platform
Asset logo for symbol IDYA
Ideaya Biosciences
IDYA52
$18.74arrow_drop_down0.72%-$0.13
Asset logo for symbol IDYA
IDYA52

$18.74

arrow_drop_down0.72%

Income Statement (IDYA)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
EBIT-$144.13M-$67.90M-$65.40M-$52.09M-$42.31M
EBITDA-$143.49M-$66.89M-$64.30M-$51.01M-$41.28M
gross Profit$7.00M--$1.09M-$1.08M$2.89M
NET Income-$130.31M-$51.82M-$52.77M-$39.57M-$33.95M
total Revenue$7.00M$0.00$0.00$0.00$3.92M

Balance Sheet (IDYA)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
cash Equivalents-----
net Debt-$65.20M-$381.48M-$181.18M-$105.93M-$154.14M
stockholders Equity$1.05B$1.18B$931.65M$935.31M$621.09M
total Assets$1.12B$1.23B$973.66M$961.52M$649.31M
total Debt$19.17M$18.79M$1.86M$2.40M$2.87M
total Liabilities$64.94M$59.45M$42.00M$26.21M$28.22M

Cash Flow (IDYA)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
financing Cash Flow$2.75M$286.50M$39.18M$349.11M$140.89M
free Cash Flow-$122.75M-$49.69M-$33.85M-$45.13M-$24.58M
investing Cash Flow-----
operating Cash Flow-$121.65M-$49.23M-$32.88M-$43.81M-$23.74M

Ideaya Biosciences (IDYA) Financials

Ideaya Biosciences Inc (IDYA) is a biotechnology company focused on the discovery and development of targeted therapeutics for genetically defined cancers. The company's financials provide valuable insights into its performance and prospects. Looking at the income statement, we can see the revenue generated by Ideaya Biosciences Inc. This reflects the total amount of money brought in from the sale of its products or services. Additionally, the income statement also shows the gross profit, which is calculated by subtracting the cost of goods sold from the revenue. This indicates how efficiently the company is managing its production costs. Another important metric is the net income from stockholders, which represents the profit earned by the company after deducting all expenses, taxes, and interest. It's a key indicator of the company's profitability and overall financial health.
Moving on to the balance sheet, we can see the financial position of Ideaya Biosciences Inc. Total assets represent the company's resources, such as cash, inventory, property, and equipment. On the other hand, total liabilities reflect the company's obligations, such as loans and accounts payable. The difference between assets and liabilities is known as stockholders' equity, which represents the net worth of the company. Cash equivalents are highly liquid assets that can be readily converted into cash, providing a measure of the company's liquidity. Net debt is the difference between a company's total debt and its cash and cash equivalents. It indicates how much debt the company would have if it used all its available cash to pay off its obligations.
Lastly, the cash flow statement provides insights into how Ideaya Biosciences Inc manages and generates cash. Operating cash flow shows the cash generated from the company's core operations. Investing cash flow reflects the company's cash spent on acquiring or selling assets, such as property or equipment. Financing cash flow represents the cash generated from activities such as issuing or repurchasing stock, or taking on or repaying debt. Free cash flow is a measure of the company's profitability and its ability to generate cash after deducting all capital expenditures. It reflects the cash available to the company for growth, debt reduction, or distribution to shareholders.
add Ideaya Biosciences  to watchlist

Keep an eye on Ideaya Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level